South Africa's National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.

It's designed to take the place of complicated, multiple drug regimens that many people with HIV need to follow. And it's ...

The World Health Organization (WHO) released landmark Consolidated guidance and implementation handbook on hepatitis B and C , to support countries ...

Newspaper articles from the colonial period about independence activist Dosan Ahn Chang-ho (1878–1938) are filled with ...

South Africa is asking local drugmakers to start a process to make Gilead Sciences’ long-acting HIV prevention drug, ...

This week in Africa: a potential breakthrough in the fight against sleeping sickness with a single-dose oral treatment, alongside a $1.2 billion health agreement between the DRC and the United States.